Drug utilization review

Main article: Drug
Drug Utilization Review
TypePharmaceuticals policy
Established1969
Area sizemajor in Koern[clarification needed] and America
Establishmentsprivate pharmaceutical management company

Drug utilization review refers to a review of prescribing, dispensing, administering and ingesting of medication.[1] This authorized, structured and ongoing review is related to pharmacy benefit managers.[2] Drug use/ utilization evaluation and medication utilization evaluations are the same as drug utilization review.[3]

With the development of society and the economy, the costs of health care grows rapidly, and this becomes a burden on the worldwide health protection system.[4] Aging populations, a changing disease spectrum, and the progress and change in technology of health care become the major problems which lead to increasing of health care costs.[4] Then, how to use drug utilization evaluation and drug economy evaluation to improve and optimize the allocation of medical and health resources is a major problem faced by many countries.[4]

Drug utilization reviews will help ensure that drugs are used appropriately (for individual patients). In the drug utilization review, medicine and health history including all phases of dispensing for a patient is exactly listed.[1] Also, this review is designed to attempt to attain proper decision making therapeutically and gain a positive outcome for the patient.[1] If treatment is considered inappropriate, it will be necessary to intervene with providers or patients to optimize medication.[5] Then, especially in the community medicine setting, Drug utilization review plays a key role for pharmacist.[6] In addition, The World Health Organization (WHO) regards drug utilization as 4 phases of drugs in society. These four phases are marketing, distribution, prescription and usage.[3]

  1. ^ a b c Academy of Managed Care Pharmacy (2009). "Drug Utilization Review". amcp.org. Archived from the original on 2018-06-15. Retrieved 2019-05-12.
  2. ^ Radloff, Tom; Jones, Steven (2007). "Patient Safety Through Drug Utilization Review". Benefits & Compensation Digest. 44 (7): 32–35.
  3. ^ a b Shimpi, R. D.; Salunkhe, P. S.; Bacaskar, S. R.; Laddha, G. P.; Kalam, A. A.; Patel, K.; Jain, S. S. (2012). "Drug utilization evaluation and prescription monitoring in asthmatic patients" (PDF). International Journal of Pharmacy and Biological Sciences. 2 (1): 117–122.
  4. ^ a b c Zhao, C.; Yue, X. (2014-11-01). "The Importance and Use of Drug Utilization Review and Pharmacoeconomics". Value in Health. 17 (7): A733. doi:10.1016/j.jval.2014.08.092. ISSN 1098-3015. PMID 27202626.
  5. ^ Holloway, Kathleen; Green, Terry (2003). "Drug and Therapeutics Committees - A Practical Guide" (PDF). Archived from the original (PDF) on June 5, 2010. Retrieved 2019-06-07.
  6. ^ Mospan, Cortney M.; Alexander, Katelyn M. (2017). "Teaching drug utilization review skills via a simulated clinical decision making exercise". Currents in Pharmacy Teaching and Learning. 9 (2): 282–287. doi:10.1016/j.cptl.2016.11.021. PMID 29233414.